ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

Detaylı Bibliyografya
Asıl Yazarlar:	Burton, A, Martin, R, Holly, J, Hamdy, F, Neal, D, Donovan, J, Tilling, K
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2011

Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring.
Yazar:: Burton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
Yazar:: Burton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Yazar:: Tilling, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Yazar:: Young, GJ, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Yazar:: Roddam, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
Yazar:: Wade, J, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Metabolic imbalance and prostate cancer progression.
Yazar:: Burton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
Yazar:: Törnblom, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
Yazar:: Ulrika Rönningås, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
Yazar:: Sävblom, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Prostate Specific Antigen (PSA): The Historical Perspective
Yazar:: T. Ming Chu
Baskı/Yayın Bilgisi: (2020-12-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
Yazar:: Amit M. Algotar PhD, MBBS, ve diğerleri
Baskı/Yayın Bilgisi: (2011-05-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
Yazar:: , DAHESIHDEWI, Andaru, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
Yazar:: Priya Duvedi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
Yazar:: Littlejohns, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
Yazar:: Jin-Woo Jung, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Yazar:: Oliver, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

PSA testing for men at average risk of prostate cancer
Yazar:: Bruce K Armstrong, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
Yazar:: Andrew J Simpkin, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
Yazar:: Zuccolo, L, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Yazar:: Oliver, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Yazar:: Simpkin, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
Yazar:: Blijenberg, BG, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
Yazar:: Hamdy, FC, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

Benzer Materyaller

Benzer Materyaller